JZZ Technologies, Inc. is a diversified technology company engaged in the following two distinct business sectors: (i) its digital media business, which includes online media and apps (activelifestylemedia(dot)com), content creation, digital marketing, streaming video content, publishing, and free over-the-air television (EyeOnTV) targeted to active adults 55+, and; (ii) strategic biotechnology and bioscience-related to Human Life Extension and Human Longevity that can be immediately leveraged to support improved quality of life for the senior population.
And right now, based on these 5 potential catalysts, this profile requires immediate attention:
No. 1 - Advancing Research Through Anticipated Venture
No. 2 - Huge Acquisition Related News Could Become Game-Changer
No. 3 - Signing Of LOI To Start New Business Venture
No. 4 - Huge Revenue Projection Moving Forward
No. 5 - Another Low Float Idea
So let's get to it...
No. 1 JZZI Potential Catalyst - Advancing Research Through Anticipated Venture
Based on Latest Research, JZZ Technologies, Inc. Announces New Immune Boost and Anti-Inflammatory Products Developed Through Nutrific Inc.
New research from GenBio Inc. working with Nutrific Inc. is focused on the body's signaling process to address inflammatory disorders and its reaction to the Cytokine Storm
West Palm Beach, Florida--(Newsfile Corp. - December 22, 2021) - JZZ Technologies, Inc., (OTC Pink: JZZI) is advancing research being forwarded by its anticipated venture with Nutrific, Inc. and GenBio Inc. in order to provide a breakthrough immune boost and anti-inflammatory product line.
The new research focuses on the body's negative reaction to viruses,... International research supports that this response is an unnatural reaction that should be treatable through immune boost and anti-inflammatory products.
The Nutrific products aim to specifically address the transduction (signaling) process in inflammatory disorders to mitigate the worst effects of a virus and the body's response to them.
These two areas represent massive markets where a relevant natural treatment could provide significant revenues through a patented treatment. The global immune health supplements market is projected to grow from $20.18Bn in 2021 to $31.50Bn in 2028 at a CAGR of 6.6% from 2021 to 2028 (source: Fortune Business Insights). Alongside the immune health market, the Global Anti-Inflammatory Therapeutics market size is estimated to grow at CAGR of almost 6% with $27.53Bn during the forecast period 2021-2024 (source: MarketWatch). These are the two markets that Nutrific expects to enter with its new products.
[...]
Read the full article here.
-----
No. 2 JZZI Potential Catalyst - Huge Acquisition Related News Could Become Game-Changer
JZZ Technologies, Inc. Signs LOI to Acquire Life Factor Research Inc
In its second acquisition in the bioscience and human longevity sector, JZZ Technologies, Inc. intends to acquire Life Factor Research Inc. and begin marketing its unique and patented line of natural supplements
West Palm Beach, Florida--(Newsfile Corp. - December 6, 2021) - JZZ Technologies, Inc., (OTC Pink: JZZI) has signed a Letter of Intent ("LOI") with life sciences company Life Factor Research Inc. of Medford, Oregon. Under the terms of the Letter of Intent, dated November 30, 2021, JZZ Technologies, Inc. will acquire 100% ownership of Life Factor Research Inc., its formulations, research, products, and manufacturing operations.
Life Factor Research Inc. is comprised of seasoned professionals dedicated to combining proven science with the very best that nature provides to create products that change lives. Their team has dedicated their professional lives to the creation, testing, and implementing of technologies - many of which are used by some of the most reputable Pharmaceutical and Nutraceutical companies in existence.
Life Factor Research's products focus on two groups: proprietary formulations and bioavailability technology. These two areas form the seedbed for the company's proprietary and patented products that deal with testosterone support, prostate support, restorative sleep, type II diabetes, and metabolic syndrome, pain analgesics, gluten sensitivity, adaptogens, and skin stem cell formulations. Several of the company's leading products are sold commercially under the Natures Balance brand name.
The new agreement also contemplates that Charles Layton and his team of researchers and scientists will continue to operate all aspects of Life Factor Research as a wholly-owned subsidiary of JZZ Technologies, Inc. Mr. Layton has a considerable history in the life sciences field and will assume the role as head of JZZ Technologies' life sciences and biotechnology operations.
Charles Layton, CEO Of Life Factor Research Inc., stated, "This acquisition is well-timed for Life Factor Research Inc. and will provide important parts to our marketing, distribution, and access to greater capital. We look forward to the new opportunities that this will create going forward and putting Life Factor Research on a global scale with our much-needed approaches and the products that they foster."
Charles Cardona, CEO of JZZ Technologies, Inc., stated, "Life Factor Research's ongoing development of products and research are an excellent fit for our direction in the life extension and biosciences. We also join with Charles Layton, who can bring his vast experience to our team and head up our life sciences and bioscience operations. This adds a huge resource to our company."
JZZ Technologies intends to provide certain working capital to Life Factor Research, whereby the two parties may achieve and initiate new products, marketing, influencer campaigns, and sales to move the venture into global commercial viability.
Read the full article here.
-----
No. 3 JZZI Potential Catalyst - Signing Of LOI To Start New Business Venture
JZZ Technologies, Inc. Joins with GenBio, Inc., Nutrific, and NutraEdge Biosciences Corp. to Create New Bioscience Products Company Focused on Breakthrough Therapeutic Products and Research
Working with respected bioscience companies GenBio, Inc., Nutrific, and NutraEdge Biosciences Corp., JZZ Technologies, Inc. intends to launch a new bioscience products venture developing and marketing novel therapeutics utilizing natural compounds for age-related healthcare issues.
Palm Beach, Florida--(Newsfile Corp. - November 16, 2021) - JZZ Technologies, Inc. (OTC Pink: JZZI) has signed a Letter Of Intent (LOI) to join with biotech company GenBio, Inc., and bioscience company Nutrific of Aliso Viejo, California, to create a new business venture in the Life Extension and Longevity sector. The new entity, which will operate under the NutraEdge Biosciences Corp. brand, contemplates utilizing product development, research, and existing human resources of GenBio, Inc., and Nutrific in its pursuit of therapeutics for various medical ailments and age-related health issues.
Under the terms, JZZ Technologies, Inc. will acquire 100% ownership of NutraEdge Biosciences Corp.
GenBio Inc. and Nutrific are focused on rapidly developing a new range of natural extracts to enhance health. GenBio CSO, Professor Lindsay Brown, a former Professor of Biomedical Sciences, University of Southern Queensland, Australia, leads the research of the company's formulations and products.
[...]
Charles Cardona, CEO of JZZ Technologies, Inc., stated, "We are very excited to be working with the world-class team that GenBio, Inc., Nutrific, and NutraEdge Biosciences Corp. bring to the table. Our focus is acting as a platform to deliver products that can potentially improve life quality and contribute to human longevity. We are confident that the NutraEdge Biosciences venture will play an industry-leading role in this important space."
[...]
Read the full article here.
-----
No. 4 JZZI Potential Catalyst - Huge Revenue Projection Moving Forward
JZZ Technologies, Inc. Projects Revenue of Over One Mn Dollars Per Month from its Recent Acquisition of Beacon Insurance Solutions
Palm Beach, Florida, Oct. 06, 2021 (GLOBE NEWSWIRE) -- With the acquisition by JZZ Technologies, Inc. (OTC Pink: JZZI) of Beacon Insurance Solutions Inc. now completed, there is a very positive outlook among both businesses toward generating significant growth in short-term revenue that is expected to quickly reach the one Mn dollars per month figure.
Tom Law, the Founder and Principal of Beacon Insurance Solutions Inc., has been at the forefront of the insurance business for decades and stated, “With the arsenal of digital tools and marketing ingenuity that JZZ Technologies brings to the table, I fully expect our monthly revenues to reach and surpass one Mn dollars per month within 12 months.”
Law went on to state, “These tools were not going to be within our reach as a stand-alone company for a long time. This new business combination will really accelerate our growth going forward and create a legacy business model that will stand out in the insurance business nationwide.”
Charles Cardona, the visionary CEO and Founder of JZZ Technologies, Inc. added insight into the business developments stating, “While the margins for the insurance industry may not be as glamorous as the high-tech sector at the 10% to 12% range, the stability and predictability of the revenue streams will more than compensate for that.”
“The insurance business is the industry that Warren Buffett used as the catalyst to provide stability and a continuously increasing inflow of cash for his other acquisitions for Berkshire Hathaway to build an enormous amount of wealth for shareholders," Cardona adds. “We expect that the stability of the revenue streams from our insurance subsidiary will be a perfect complement to the higher margins of the technology side of JZZ Technologies, Inc. as we begin producing revenue from our marketing database, which has recently been valued at over $13.1Mn by a verified third-party expert in the field.”
Read the full article here.
-----
No. 5 JZZI Potential Catalyst - Another Low Float Idea
According to the OTC Markets website (as of 9/30/14), JZZI has a low float.
The website reports this profile to have approximately 6.03Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility.
With so few shares available for trading, other potential catalysts could help spark a vertical move in the short-term.
-----
Recap: 5 Potential Catalysts For New Breakout Idea (JZZI)
No. 1 - Advancing Research Through Anticipated Venture
No. 2 - Huge Acquisition Related News Could Become Game-Changer
No. 3 - Signing Of LOI To Start New Business Venture
No. 4 - Huge Revenue Projection Moving Forward
No. 5 - Another Low Float Idea
-----
Coverage is officially initiated on JZZI. When you have time later, do this:
